Leptin reduces hyperphagia and insulin resistance in liver and muscle in patients with lipodystrophy [185], and this fact together the data mentioned above increases the interest in possible treatment of T1DM patients with this cytokine, as these patients often present with weight loss and hyperphagia as a consequence of complete or partial insulin deficiency. This evidence concerns the gene LEP and type 1 diabetes mellitus.